Overexpression of VEGF1 was associated with worse 3-year PFS for ALK-negative ALCL (100% for VEGF1 < median and 76,19% for VEGF1 ≥ median; HR 1.74,0.869–3.760, p = 0.04). The gene discussed is ALK; the disease is anaplastic large cell lymphoma.